Yoshimura Y
Department of Obstetrics and Gynecology, Kyorin University School of Medicine, Tokyo.
Nihon Sanka Fujinka Gakkai Zasshi. 1995 Aug;47(8):763-74.
The concept of classical endocrine control of ovarian function has now been extended to a more complex regulator system, including paracrine and autocrine modulating mechanisms. Among many factors, locally produced intraovarian insulin-like growth factors (IGFs) and the binding proteins (IGFBPs) and renin-angiotensin system (RAS) have been shown to play an important role in the control of folliculogenesis and ovulation. Growth hormone (GH) amplified gonadotropin actions in the process of follicular development and ovulation, at least in part, stimulating ovarian IGF-I production. IGF-I as well as IGFBPs were produced by ovarian granulosa cells. IGF-I acted synergistically with gonadotropins in the stimulation of a variety of granulosa cell functions, including estradiol (E2) and progesterone production and plasminogen activator (PA) activity. Furthermore, rabbit ovarian cells and rat granulosa cells possessed specific IGF type I receptors. The biological effects of IGF-I, including intrafollicular PA activities and ovarian steroidogenesis, were modulated by a family of IGFBPs in a complex manner. In the ovary IGFBP-3 appeared to neutralize the actions of gonadotropin and IGF-I, probably via its ability to sequester IGF-I, in the process of follicular growth, oocyte maturation, and ovulation. A functional local RAS is also known to exist in the ovary. Angiotensin II (Ang II) at 2-h intervals induced oocyte maturation, ovulation, and the production of E2 and prostaglandins (PGs) in the in vitro perfused rabbit ovaries in the absence of gonadotropin. In addition, the intrafollicular Ang II content and renin-like activity were enhanced during the ovulatory process by exposure to hCG, and the concomitant addition of saralasin inhibited hCG-induced ovulation in a dose-dependent manner. Captopril, an inhibitor of angiotensin converting enzyme, significantly inhibited the resumption of meiosis in the ovulated ova and follicular oocytes stimulated by hCG. Autoradiographic study revealed that AT2 receptors were predominantly located in granulosa cells, whereas AT1 receptors were more concentrated in the stroma and the thecal layers. Ang II-stimulated production of E2 and PGs and ovulation were significantly blocked by PD123319, a selective nonpeptide antagonist for AT2 receptors. The increase in ovarian IGF-I synthesis by exposure to hCG or GH induced the stimulation of intrafollicular PA activities. IGFBP-3 blocked the stimulatory effects of gonadotropin in the ovulatory process by neutralizing endogenously produced IGF-I, resulting in reduced intrafollicular PA activities. The increase in intrafollicular PA activities significantly stimulated the generation of Ang II in the preovulatory follicles by an activation of prorenin to renin and/or by the direct cleavage of angiotensinogen.(ABSTRACT TRUNCATED AT 400 WORDS)
卵巢功能的经典内分泌控制概念现已扩展到一个更复杂的调节系统,包括旁分泌和自分泌调节机制。在众多因素中,局部产生的卵巢内胰岛素样生长因子(IGFs)、结合蛋白(IGFBPs)和肾素 - 血管紧张素系统(RAS)已被证明在卵泡发生和排卵的控制中起重要作用。生长激素(GH)在卵泡发育和排卵过程中至少部分地增强促性腺激素的作用,刺激卵巢IGF - I的产生。IGF - I以及IGFBPs由卵巢颗粒细胞产生。IGF - I与促性腺激素协同作用,刺激多种颗粒细胞功能,包括雌二醇(E2)和孕酮的产生以及纤溶酶原激活物(PA)活性。此外,兔卵巢细胞和大鼠颗粒细胞具有特异性IGF I型受体。IGF - I的生物学效应,包括卵泡内PA活性和卵巢类固醇生成,受到一系列IGFBPs的复杂调节。在卵巢中,IGFBP - 3似乎通过其隔离IGF - I的能力,在卵泡生长、卵母细胞成熟和排卵过程中中和促性腺激素和IGF - I的作用。已知卵巢中还存在功能性局部RAS。在无促性腺激素的情况下,每隔2小时给予血管紧张素II(Ang II)可诱导体外灌注兔卵巢中的卵母细胞成熟、排卵以及E2和前列腺素(PGs)的产生。此外,在排卵过程中,通过暴露于hCG可增强卵泡内Ang II含量和肾素样活性,同时添加沙拉新可剂量依赖性地抑制hCG诱导的排卵。血管紧张素转换酶抑制剂卡托普利可显著抑制hCG刺激的排卵卵母细胞和卵泡卵母细胞减数分裂的恢复。放射自显影研究表明,AT2受体主要位于颗粒细胞中,而AT1受体更集中于基质和卵泡膜层。AT2受体的选择性非肽拮抗剂PD123319可显著阻断Ang II刺激的E2和PGs产生以及排卵。暴露于hCG或GH导致卵巢IGF - I合成增加,从而刺激卵泡内PA活性。IGFBP - 3通过中和内源性产生的IGF - I来阻断促性腺激素在排卵过程中的刺激作用,导致卵泡内PA活性降低。卵泡内PA活性的增加通过将肾素原激活为肾素和/或直接裂解血管紧张素原,显著刺激排卵前卵泡中Ang II 的生成。(摘要截断于400字)